Literature DB >> 18983490

Duration of anticoagulation and risk of recurrent thromboembolism in carriers of factor V Leiden or prothrombin mutation.

P Prandoni, D Tormene, L Spiezia, R Pesavento, P Simioni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18983490     DOI： 10.1111/j.1538-7836.2008.03173.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  3 in total

Review 1.  Optimal duration of anticoagulation in patients with venous thromboembolism.

Authors:  Paolo Prandoni; Chiara Piovella; Luca Spiezia; Fabio Dalla Valle; Raffaele Pesavento
Journal:  Indian J Med Res       Date:  2011-07       Impact factor: 2.375

2.  Current Knowledge on Factor V Leiden Mutation as a Risk Factor for Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis.

Authors:  Daria Eppenberger; Henning Nilius; Betsy Anagnostelis; Carola A Huber; Michael Nagler
Journal:  Front Cardiovasc Med       Date:  2022-04-07

Review 3.  Recurrent venous thromboembolism: what is the risk and how to prevent it.

Authors:  Gualtiero Palareti
Journal:  Scientifica (Cairo)       Date:  2012-09-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.